Archive - August 2019
Rozlytrek bags FDA approval
£500,000 injected into ‘innovative’ AI online safety software
Terlipressin hits phase III endpoint
Government to reconsider NHS Health Checks
NHS toolkit launched for progressive neurological conditions
Medical Devices’ Big Regulatory Shake-Up: What Now?
Sanofi patent case win holds off generic rivals for key cancer drug
Leo Pharma to market AstraZeneca’s brodalumab outside Europe